Mechanisms of persistent activation of the androgen receptor in CRPC: Recent advances and future perspectives

Nagalakshmi Nadiminty, Allen C Gao

Research output: Contribution to journalArticle

27 Citations (Scopus)

Abstract

Background: The emergence of castration resistance has remained the primary obstacle in prostate cancer therapy for several decades. Mechanisms likely to be involved in castration-resistant progression have been studied extensively, but have failed to yield many meaningful and effective targets. The re-activation of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC) is now recognized as the central event in this process, and therapeutic modalities are being devised to combat it. Methods: A review of literature was performed to highlight the important factors that play a role in the aberrant activation of the AR in CRPC. Results: Seminal and exciting advances made in the past few years in the discovery of the roles of new intrinsic factors such as intracrine androgens, gene fusions involving the ETS oncogenes, and splice variants of the AR are reviewed. New and emerging hypotheses about the involvement of factors such as cytokines and other signaling pathways are discussed. Conclusions: This review summarizes the most recent advances in the persistent activation of the androgen receptor signaling pathway and provides a perspective about their significance in CRPC progression.

Original languageEnglish (US)
Pages (from-to)287-295
Number of pages9
JournalWorld Journal of Urology
Volume30
Issue number3
DOIs
StatePublished - Jun 2012

Fingerprint

Castration
Androgen Receptors
Prostatic Neoplasms
Intrinsic Factor
Gene Fusion
Oncogenes
Androgens
Cytokines
Therapeutics

Keywords

  • Androgen receptor
  • Castration-resistant prostate cancer
  • Cytokines
  • Intracrine androgens
  • Splice variants

ASJC Scopus subject areas

  • Urology

Cite this

Mechanisms of persistent activation of the androgen receptor in CRPC : Recent advances and future perspectives. / Nadiminty, Nagalakshmi; Gao, Allen C.

In: World Journal of Urology, Vol. 30, No. 3, 06.2012, p. 287-295.

Research output: Contribution to journalArticle

@article{f8adda710a2445508f03edee84dc8782,
title = "Mechanisms of persistent activation of the androgen receptor in CRPC: Recent advances and future perspectives",
abstract = "Background: The emergence of castration resistance has remained the primary obstacle in prostate cancer therapy for several decades. Mechanisms likely to be involved in castration-resistant progression have been studied extensively, but have failed to yield many meaningful and effective targets. The re-activation of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC) is now recognized as the central event in this process, and therapeutic modalities are being devised to combat it. Methods: A review of literature was performed to highlight the important factors that play a role in the aberrant activation of the AR in CRPC. Results: Seminal and exciting advances made in the past few years in the discovery of the roles of new intrinsic factors such as intracrine androgens, gene fusions involving the ETS oncogenes, and splice variants of the AR are reviewed. New and emerging hypotheses about the involvement of factors such as cytokines and other signaling pathways are discussed. Conclusions: This review summarizes the most recent advances in the persistent activation of the androgen receptor signaling pathway and provides a perspective about their significance in CRPC progression.",
keywords = "Androgen receptor, Castration-resistant prostate cancer, Cytokines, Intracrine androgens, Splice variants",
author = "Nagalakshmi Nadiminty and Gao, {Allen C}",
year = "2012",
month = "6",
doi = "10.1007/s00345-011-0771-3",
language = "English (US)",
volume = "30",
pages = "287--295",
journal = "World Journal of Urology",
issn = "0724-4983",
publisher = "Springer Verlag",
number = "3",

}

TY - JOUR

T1 - Mechanisms of persistent activation of the androgen receptor in CRPC

T2 - Recent advances and future perspectives

AU - Nadiminty, Nagalakshmi

AU - Gao, Allen C

PY - 2012/6

Y1 - 2012/6

N2 - Background: The emergence of castration resistance has remained the primary obstacle in prostate cancer therapy for several decades. Mechanisms likely to be involved in castration-resistant progression have been studied extensively, but have failed to yield many meaningful and effective targets. The re-activation of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC) is now recognized as the central event in this process, and therapeutic modalities are being devised to combat it. Methods: A review of literature was performed to highlight the important factors that play a role in the aberrant activation of the AR in CRPC. Results: Seminal and exciting advances made in the past few years in the discovery of the roles of new intrinsic factors such as intracrine androgens, gene fusions involving the ETS oncogenes, and splice variants of the AR are reviewed. New and emerging hypotheses about the involvement of factors such as cytokines and other signaling pathways are discussed. Conclusions: This review summarizes the most recent advances in the persistent activation of the androgen receptor signaling pathway and provides a perspective about their significance in CRPC progression.

AB - Background: The emergence of castration resistance has remained the primary obstacle in prostate cancer therapy for several decades. Mechanisms likely to be involved in castration-resistant progression have been studied extensively, but have failed to yield many meaningful and effective targets. The re-activation of the androgen receptor (AR) in castration-resistant prostate cancer (CRPC) is now recognized as the central event in this process, and therapeutic modalities are being devised to combat it. Methods: A review of literature was performed to highlight the important factors that play a role in the aberrant activation of the AR in CRPC. Results: Seminal and exciting advances made in the past few years in the discovery of the roles of new intrinsic factors such as intracrine androgens, gene fusions involving the ETS oncogenes, and splice variants of the AR are reviewed. New and emerging hypotheses about the involvement of factors such as cytokines and other signaling pathways are discussed. Conclusions: This review summarizes the most recent advances in the persistent activation of the androgen receptor signaling pathway and provides a perspective about their significance in CRPC progression.

KW - Androgen receptor

KW - Castration-resistant prostate cancer

KW - Cytokines

KW - Intracrine androgens

KW - Splice variants

UR - http://www.scopus.com/inward/record.url?scp=84861649301&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861649301&partnerID=8YFLogxK

U2 - 10.1007/s00345-011-0771-3

DO - 10.1007/s00345-011-0771-3

M3 - Article

C2 - 22009116

AN - SCOPUS:84861649301

VL - 30

SP - 287

EP - 295

JO - World Journal of Urology

JF - World Journal of Urology

SN - 0724-4983

IS - 3

ER -